Regulus Therapeutics Inc • RGLS

Capital at risk.

About Regulus Therapeutics Inc
Ticker
info
RGLS
Trading on
info
NASDAQ
ISIN
info
US75915K3095
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Joseph P. Hagan M.B.A.
Headquarters
info
4224 Campus Point Court, San Diego, CA, United States, 92121
Employees
info
34
Website
info
regulusrx.com
Regulus Therapeutics Inc. engages in the development of drugs designed to inhibit dysregulated microRNA targets for the benefit of patients with genetically based orphan diseases. The company develops farabursen, an anti-miR oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease. It is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was formerly known as Regulus Therapeutics LLC and changed its name to Regulus Therapeutics Inc. in January 2009. The company was incorporated in 2007 and is based in San Diego, California. As of June 25, 2025, Regulus Therapeutics Inc. operates as a subsidiary of Novartis AG.
Metrics
BasicAdvanced
Market cap
info
$565M
P/E ratio
info
-
EPS
info
-$0.68
Dividend Yield
info
0.00%
Beta
info
0.37
Forward P/E ratio
info
0
EBIDTA
info
$-51.4M
Ex dividend date
info
-
Price & volume
Market cap
info
$565M
Average daily volume
info
-
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-0.04
Trailing P/E
info
0
Price to sales
info
7.43
Price to book
info
8.19
Earnings
EPS
info
-$0.68
EPS estimate (current quarter)
info
-$0.27
EPS estimate (next quarter)
info
-$0.31
EBITDA
info
$-51.4M
Revenues (TTM)
info
$5M
Revenues per share (TTM)
info
$0.07
Technicals
Beta
info
0.37
52-week High
info
$8.35
52-week Low
info
$0.83
50-day moving average
info
$7.14
200-day moving average
info
$2.89
Short ratio
info
1.57
Short %
info
3.23%
Management effectiveness
ROE (TTM)
info
-53.82%
ROA (TTM)
info
-34.23%
Profit margin
info
0.00%
Gross profit margin
info
$-36.1M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
27,677.80%
Share stats
Outstanding Shares
info
69.2M
Float
info
57.7M
Insiders %
info
2.71%
Institutions %
info
82.87%
Analyst Insights & forecasts
info

34% Buy

66% Hold

0% Sell

Based on information from 6 analysts.

Average price target

info
$7.00
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.17
-$0.15
-13.33%
Q2 • 24Missed
-$0.21
-$0.17
-23.53%
Q3 • 24Missed
-$0.20
-$0.22
10.11%
Q4 • 24Beat
-$0.15
-$0.27
43.40%
Q1 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-12.8M
-∞%
Q4 • 24
$0.3M
$-9.6M
-2,833.53%
Q1 • 25
∞%
-24.68%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$84.2M
$7.8M
9.23%
Q4 • 24
$74.8M
$5.8M
7.75%
Q1 • 25
-11.11%
-25.41%
-16.08%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-11.8M
$24M
$0M
$-11.8M
Q4 • 24
$-10.6M
$21.5M
$0M
$-10.3M
Q1 • 25
-10.40%
-10.42%
∞%
-12.66%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Regulus Therapeutics Inc share?
Collapse

Regulus Therapeutics Inc shares are currently traded for undefined per share.

How many shares does Regulus Therapeutics Inc have?
Collapse

Regulus Therapeutics Inc currently has 69.2M shares.

Does Regulus Therapeutics Inc pay dividends?
Collapse

No, Regulus Therapeutics Inc doesn't pay dividends.

What is Regulus Therapeutics Inc 52 week high?
Collapse

Regulus Therapeutics Inc 52 week high is $8.35.

What is Regulus Therapeutics Inc 52 week low?
Collapse

Regulus Therapeutics Inc 52 week low is $0.83.

What is the 200-day moving average of Regulus Therapeutics Inc?
Collapse

Regulus Therapeutics Inc 200-day moving average is $2.89.

Who is Regulus Therapeutics Inc CEO?
Collapse

The CEO of Regulus Therapeutics Inc is Joseph P. Hagan M.B.A..

How many employees Regulus Therapeutics Inc has?
Collapse

Regulus Therapeutics Inc has 34 employees.

What is the market cap of Regulus Therapeutics Inc?
Collapse

The market cap of Regulus Therapeutics Inc is $565M.

What is the P/E of Regulus Therapeutics Inc?
Collapse

The current P/E of Regulus Therapeutics Inc is null.

What is the EPS of Regulus Therapeutics Inc?
Collapse

The EPS of Regulus Therapeutics Inc is -$0.68.

What is the PEG Ratio of Regulus Therapeutics Inc?
Collapse

The PEG Ratio of Regulus Therapeutics Inc is -0.04.

What do analysts say about Regulus Therapeutics Inc?
Collapse

According to the analysts Regulus Therapeutics Inc is considered a hold.